TGR analysis in phase I clinical trials--letter.
Authors' Affiliations: Sage Bionetworks, Fred Hutchinson Cancer Research Center, Seattle, Washington and Molecular Therapeutics Research Unit, Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Rodrigo
R
Dienstmann
Josep
J
Tabernero
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents